Hemophilia Market Size to Hit USD 24.2 Billion by 2032, Driven by Advancements in Gene Therapy and Innovative Treatment Solutions – SNS Insider
12. März 2025 09:00 ET
|
SNS Insider pvt ltd
Pune, March 12, 2025 (GLOBE NEWSWIRE) -- Hemophilia Market Size & Growth Analysis: “According to SNS Insider, the Hemophilia Market was valued at USD 13.7 billion in 2023 and is projected to...
Hemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight
18. Februar 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Hemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight The hemophilia market is expected to...
Blood Plasma Derivatives Market Insights and Forecast 2025-2030 - Grifols, SK Plasma, and Fusion Health Care Lead the Competition
06. Februar 2025 06:07 ET
|
Research and Markets
Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Blood Plasma Derivatives Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type"...
$15.7 Bn Haemophilia Treatment Market - Global Industry Trends Opportunities, and Forecasts, 2020-2030
13. Januar 2025 11:18 ET
|
Research and Markets
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Haemophilia Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F" report has been added to ...
$115+ Billion Blood Plasma Derivatives Global Market Trends, Opportunities and Strategies to 2033: Innovative Formulations, Strategic Partnerships, and Increasing Investments to Drive Developments
28. November 2024 07:01 ET
|
Research and Markets
Dublin, Nov. 28, 2024 (GLOBE NEWSWIRE) -- The "Blood Plasma Derivatives Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.Growth in the...
Hemophilia Markets Poised for Evolution as Competitive Dynamics between Hemlibra (Roche/Genentech) and Altuviiio (Sanofi) Intensify and Hympavzi (Pfizer) Receives Approval, According to Spherix Global Insights
14. Oktober 2024 12:33 ET
|
Spherix Global Insights
EXTON, PA, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Hemophilia, a genetic disorder that impairs blood clotting, affects thousands of people worldwide. The treatment landscape is rapidly evolving, fueled by...
Hematology Collaboration and Licensing Deals Analysis Report and Directory 2024: Company A-Z, Headline Value, Therapeutic Area, Technology Type, Royalties
30. September 2024 05:14 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.The report provides access to deal...
2024 Annual Eric Dostie Memorial College Scholarship Recipients
24. September 2024 13:34 ET
|
FFF Enterprises.com
TEMECULA, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc. announces its 2024 Eric Dostie Memorial College Scholarship...
2024 Research Report | Hematology Analyzers and Reagents Market Anticipated to Reach USD 8.8 Billion by 2029
05. September 2024 11:22 ET
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Market Size, Share & Trends by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price...
Global Plasma Derived Therapies Market to Surpass US$58 Billion by 2028 with Robust Growth in Immunoglobulin and Albumin Segments
11. Juni 2024 09:14 ET
|
Research and Markets
Dublin, June 11, 2024 (GLOBE NEWSWIRE) -- The "Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast (2024-2028)" report has been added to ...